CervoMed (CRVO) Change in Accured Expenses (2010 - 2026)

CervoMed has reported Change in Accured Expenses for 17 years, with the latest figure at -$1.1 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 284.42% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22303.0 (down 96.69% YoY) and the FY2025 annual result came in at $834157.0, up 20.84% from the prior year.
• Change in Accured Expenses eased to -$1.1 million in Q1 2026 per CRVO's latest filing, from -$48096.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $1.1 million in Q3 2024 and troughed at -$1.1 million in Q1 2026.
• A 5-year average of $113638.6 and a median of $158332.0 in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses tumbled 15170.36% in 2022, then jumped 1196.12% in 2023.
• Over 5 years, Change in Accured Expenses stood at $158332.0 in 2022, then jumped by 272.64% to $590016.0 in 2023, then sank by 65.44% to $203906.0 in 2024, then plunged by 123.59% to -$48096.0 in 2025, then tumbled by 2181.46% to -$1.1 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.1 million, -$48096.0, and $454084.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.